PRT-543

N/A

Report date: 2023/05/05 17:37:17
NME

Base Information

Drug NamePRT-543
Drug Alias NamePRT-543C-220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine methyltransferase 5 inhibitors
TargetsProtein arginine methyltransferase 5
Therapy Area/IndicationsPrimary MyelofibrosisCarcinoma, Non-Small-Cell LungCarcinoma, Adenoid Cystic +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrelude Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrelude Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisCarcinoma, Non-Small-Cell LungCarcinoma, Adenoid Cystic +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A